Impax Laboratories

Impax Laboratories, Inc. is a technology-based specialty Pharmaceutical company applying its formulation expertize and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.
Type
Public
HQ
Hayward, US
Founded
1999
Size (employees)
1,495 (est)+16%
Impax Laboratories was founded in 1999 and is headquartered in Hayward, US

Impax Laboratories Office Locations

Impax Laboratories has offices in Hayward, Philadelphia, Chalfont, Zhunan Township and in 1 other location
Hayward, US (HQ)
30831 Huntwood Ave
Zhunan Township, TW
No. 1, Ke Dong 3rd Road Jhunan Science Park Miaoli County 350
Chalfont, US
121 New Britain Blvd
Philadelphia, US
3735 Castor Ave

Impax Laboratories Data and Metrics

Impax Laboratories Financial Metrics

Impax Laboratories's revenue was reported to be $824.4 m in FY, 2016 which is a 4% decrease from the previous period.
USD

Revenue (FY, 2016)

824.4 m

Revenue growth (FY, 2015 - FY, 2016), %

(4%)

Net income (FY, 2016)

(472 m)

Market capitalization (23-Jun-2017)

1.2 b

Closing share price (23-Jun-2017)

16.5

Cash (31-Dec-2015)

340.4 m
Impax Laboratories's current market capitalization is $1.2 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

511.5 m596 m860.5 m824.4 m

Revenue growth, %

17%44%(4%)

Cost of goods sold

312.2 m283.4 m508.1 m

Gross profit

199.3 m312.7 m352.4 m

Gross profit Margin, %

39%52%41%

Operating expense total

205.7 m223.8 m282.8 m

EBIT

(6.4 m)88.8 m69.6 m

EBIT margin, %

(1%)15%8%

Interest expense

(419 k)(43 k)(27.3 m)

Interest income

1.3 m1.5 m1 m

Pre tax profit

146.9 m90.6 m59.4 m

Income tax expense

45.7 m33.2 m20.4 m

Net Income

101.3 m57.4 m39 m(472 m)
USDFY, 2013FY, 2014FY, 2015

Cash

184.6 m214.9 m340.4 m

Accounts Receivable

113 m146.5 m324.5 m

Inventories

12.7 m33.7 m31.7 m

Current Assets

659.7 m730.5 m822.1 m

PP&E

188.2 m188.2 m214.2 m

Goodwill

27.6 m27.6 m210.2 m

Total Assets

996.9 m1.1 b1.9 b

Accounts Payable

26.8 m32 m56.3 m

Current Liabilities

153.9 m158.7 m326.8 m

Additional Paid-in Capital

336.6 m364.1 m504.1 m

Retained Earnings

473.9 m531.2 m570.2 m

Total Equity

1.1 b

Financial Leverage

1.8 x
USDFY, 2013FY, 2014FY, 2015

Net Income

101.3 m57.4 m39 m

Depreciation and Amortization

36 m34 m68.6 m

Accounts Receivable

(21 m)(33 m)(120 m)

Inventories

7.1 m(24 m)(5.9 m)

Accounts Payable

4.7 m(9 m)48.1 m

Cash From Operating Activities

149.9 m32.8 m71.9 m

Purchases of PP&E

(32.8 m)(29.9 m)(25.2 m)

Cash From Investing Activities

(115.9 m)(16.6 m)(467.5 m)

Cash From Financing Activities

9 m14.4 m521.4 m

Interest Paid

89 k15.4 m

Income Taxes Paid

34.3 m43.2 m

Impax Laboratories Market Value History

Impax Laboratories Median Salaries

Source: 25 public H-1B filings from Impax Laboratories

Impax Laboratories Company Life and Culture

You may also be interested in